Sep 23 |
Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
|
Sep 20 |
Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia
|
Aug 26 |
BofA starts Biohaven at buy, cites "fast-follower" approach
|
Aug 9 |
Biohaven Non-GAAP EPS of -$3.50 misses by $1.80
|
Aug 9 |
Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In?
|
Aug 8 |
Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
|
Jul 26 |
Biohaven: Taldefgrobep Alfa Might Have A Place Beyond SMA Treatment
|
Jul 24 |
Morgan Stanley starts Biohaven at overweight, cites broad pipeline
|
Jul 22 |
$1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying
|
May 29 |
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
|